Review of empagliflozin monotherapy for previously untreated patients with type 2 diabetes mellitus: Comparison with sitagliptin.

about

Review of empagliflozin monotherapy for previously untreated patients with type 2 diabetes mellitus: Comparison with sitagliptin.

Item

http://www.wikidata.org/entity/Q38365957

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Review of empagliflozin monoth ...... : Comparison with sitagliptin.

@en

type

Item

label

Review of empagliflozin monoth ...... : Comparison with sitagliptin.

@en

prefLabel

Review of empagliflozin monoth ...... : Comparison with sitagliptin.

@en

P1476

Review of empagliflozin monoth ...... : Comparison with sitagliptin.

@en

P2093

Susan Cornell

http://www.w3.org/2001/XMLSchema#string

P2860

Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Renal sodium glucose cotransporter 2 inhibitors as a novel therapeutic approach to treatment of type 2 diabetes: Clinical data and mechanism of action

Rationale, design, and baseline characteristics of a randomized, placebo-controlled cardiovascular outcome trial of empagliflozin (EMPA-REG OUTCOME™)

American Association of Clinical Endocrinologists' comprehensive diabetes management algorithm 2013 consensus statement--executive summary.

Empagliflozin, a novel selective sodium glucose cotransporter-2 (SGLT-2) inhibitor: characterisation and comparison with other SGLT-2 inhibitors.

Inhibition of renal glucose reabsorption: a novel strategy for achieving glucose control in type 2 diabetes mellitus.

Sodium-glucose cotransporter 2 inhibitors for type 2 diabetes: a systematic review and meta-analysis.

Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80,000 people

Diabetes pharmacotherapy in 2012: considerations in medication selection.

Empagliflozin: a review of its use in patients with type 2 diabetes mellitus.

P304

277-281

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/00325481.2015.1018798

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

127

http://www.w3.org/2001/XMLSchema#string

P577

2015-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272945858

http://www.w3.org/2001/XMLSchema#string

P698

25724655

http://www.w3.org/2001/XMLSchema#string